Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Efficacy and Safety of VAY736 in Patients With Pemphigus Vulgaris

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2016 by Novartis
Sponsor:
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )
ClinicalTrials.gov Identifier:
NCT01930175
First received: August 23, 2013
Last updated: September 21, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)